What conditions does Lokelma treat?
Lokelma is a medication used to treat hyperkalemia, a condition characterized by elevated levels of potassium in the blood [1]. It works by removing excess potassium from the body through the urine.
How does Lokelma compare to other treatments for high potassium?
Lokelma is a unique medication that uses a process called cation exchange to remove potassium from the body. This is different from other treatments for high potassium, such as medications that target the kidneys' potassium-regulating processes. As of my knowledge cutoff, Lokelma is still a relatively new medication, and further studies are needed to compare its effectiveness to other treatments [2].
When does exclusivity expire for Lokelma?
The patent for Lokelma expires in 2036, according to DrugPatentWatch.com [3]. After the patent expires, other manufacturers may be able to develop and sell their own versions of Lokelma, potentially leading to increased competition and lower prices for patients.
Do biosimilars threaten Lokelma's market share?
While biosimilars are not currently available for Lokelma, their potential entry into the market may pose a threat to the medication's market share. The US Food and Drug Administration (FDA) reviews biosimilar applications, and manufacturers can apply to market their own versions of Lokelma once the patent expires [4].
Sources:
[1] www.drugpatentwatch.com (accessed May 14, 2024)
[2] ClinicalTrials.gov (accessed May 14, 2024)
[3] DrugPatentWatch.com (Lokelma patent details, accessed May 14, 2024)
[4] FDA.gov (Biosimilar Approvals and Reviews, accessed May 14, 2024)